Cargando…
Risk factors for severe COVID-19 in people with cystic fibrosis: A systematic review
BACKGROUND: People with cystic fibrosis (CF) are considered a clinically fragile population with an intrinsic higher risk of developing severe COVID-19, though a certain variability in terms of outcomes and hospitalization has been noticed. AIM: To highlight the main risk factors for severe COVID-19...
Autores principales: | Terlizzi, Vito, Motisi, Marco Antonio, Pellegrino, Roberta, Padoan, Rita, Chiappini, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393295/ https://www.ncbi.nlm.nih.gov/pubmed/36003489 http://dx.doi.org/10.3389/fped.2022.958658 |
Ejemplares similares
-
Management of pulmonary aspergillosis in children: a systematic review
por: Terlizzi, Vito, et al.
Publicado: (2023) -
Stenotrophomonas maltophilia in people with Cystic Fibrosis: a systematic review of prevalence, risk factors and management
por: Terlizzi, Vito, et al.
Publicado: (2023) -
Management of respiratory tract exacerbations in people with cystic fibrosis: Focus on imaging
por: Landini, Nicholas, et al.
Publicado: (2023) -
Vasculitis in Cystic Fibrosis
por: Sposito, Francesca, et al.
Publicado: (2020) -
Case Report: Analysis of Inflammatory Cytokines IL-6, CCL2/MCP1, CCL5/RANTES, CXCL9/MIG, and CXCL10/IP10 in a Cystic Fibrosis Patient Cohort During the First Wave of the COVID-19 Pandemic
por: Baresi, Giulia, et al.
Publicado: (2021)